Literature DB >> 2105271

Expression of the Bacillus anthracis protective antigen gene by baculovirus and vaccinia virus recombinants.

L C Iacono-Connors1, C S Schmaljohn, J M Dalrymple.   

Abstract

The gene encoding Bacillus anthracis protective antigen (PA) was modified by site-directed mutagenesis, subcloned into baculovirus and vaccinia virus plasmid transfer vectors (pAcYM1 and pSC-11, respectively), and inserted via homologous recombinations into baculovirus Autographa californica nuclear polyhedrosis virus or vaccinia virus (strains WR and Connaught). Expression of PA was detected in both systems by immunofluorescence assays with antisera from rabbits immunized with B. anthracis PA. Western blot (immunoblot) analysis showed that the expressed product of both systems was slightly larger (86 kilodaltons) than B. anthracis-produced PA (83.5 kilodaltons). Analysis of trypsin digests of virus-expressed and authentic PA suggested that the size difference was due to the presence of a signal sequence remaining with the virus-expressed protein. Immunization of mice with either recombinant baculovirus-infected Spodoptera frugiperda cells or with vaccinia virus recombinants elicited a high-titer, anti-PA antibody response.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2105271      PMCID: PMC258464          DOI: 10.1128/iai.58.2.366-372.1990

Source DB:  PubMed          Journal:  Infect Immun        ISSN: 0019-9567            Impact factor:   3.441


  39 in total

1.  Purification of factor I and recognition of a third factor of the anthrax toxin.

Authors:  J L STANLEY; H SMITH
Journal:  J Gen Microbiol       Date:  1961-09

2.  Large-scale production of protective antigen of Bacillus anthracis in anaerobic cultures.

Authors:  M PUZISS; L C MANNING; J W LYNCH; I ABELOW; G G WRIGHT
Journal:  Appl Microbiol       Date:  1963-07

3.  Polyglutamic acid from Bacillus anthracis grown in vivo; structure and aggressin activity.

Authors:  H T ZWARTOUW; H SMITH
Journal:  Biochem J       Date:  1956-07       Impact factor: 3.857

4.  Synthesis of glutamic acid and glutamyl polypeptide by Bacillus anthracis. II. The effect of carbon dioxide on peptide production on solid media.

Authors:  C B THORNE; C G GOMEZ; R D HOUSEWRIGHT
Journal:  J Bacteriol       Date:  1952-03       Impact factor: 3.490

5.  Comparative efficacy of Bacillus anthracis live spore vaccine and protective antigen vaccine against anthrax in the guinea pig.

Authors:  S F Little; G B Knudson
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

6.  Development of antibodies to protective antigen and lethal factor components of anthrax toxin in humans and guinea pigs and their relevance to protective immunity.

Authors:  P C Turnbull; M G Broster; J A Carman; R J Manchee; J Melling
Journal:  Infect Immun       Date:  1986-05       Impact factor: 3.441

7.  Base composition-independent hybridization in tetramethylammonium chloride: a method for oligonucleotide screening of highly complex gene libraries.

Authors:  W I Wood; J Gitschier; L A Lasky; R M Lawn
Journal:  Proc Natl Acad Sci U S A       Date:  1985-03       Impact factor: 11.205

8.  Vaccinia virus: a selectable eukaryotic cloning and expression vector.

Authors:  M Mackett; G L Smith; B Moss
Journal:  Proc Natl Acad Sci U S A       Date:  1982-12       Impact factor: 11.205

9.  Purification and properties of in vitro-produced anthrax toxin components.

Authors:  D C Fish; B G Mahlandt; J P Dobbs; R E Lincoln
Journal:  J Bacteriol       Date:  1968-03       Impact factor: 3.490

10.  Macrophages are sensitive to anthrax lethal toxin through an acid-dependent process.

Authors:  A M Friedlander
Journal:  J Biol Chem       Date:  1986-06-05       Impact factor: 5.157

View more
  7 in total

1.  Synthesis of tetanus toxin fragment C in insect cells by use of a baculovirus expression system.

Authors:  I G Charles; B C Rodgers; A J Makoff; S N Chatfield; D E Slater; N F Fairweather
Journal:  Infect Immun       Date:  1991-05       Impact factor: 3.441

2.  Cloning, expression and purification of binding domains of lethal factor and protective antigen of Bacillus anthracis in Escherichia coli and evaluation of their related murine antibody.

Authors:  Mehdi Rezaee; Hossein Honari; Mohammad Reza Ashrafi Kooshk
Journal:  Mol Biol Rep       Date:  2014-01-16       Impact factor: 2.316

3.  Protection against anthrax with recombinant virus-expressed protective antigen in experimental animals.

Authors:  L C Iacono-Connors; S L Welkos; B E Ivins; J M Dalrymple
Journal:  Infect Immun       Date:  1991-06       Impact factor: 3.441

4.  Immunization against anthrax with Bacillus anthracis protective antigen combined with adjuvants.

Authors:  B E Ivins; S L Welkos; S F Little; M H Crumrine; G O Nelson
Journal:  Infect Immun       Date:  1992-02       Impact factor: 3.441

5.  Vaccination against anthrax with attenuated recombinant strains of Bacillus anthracis that produce protective antigen.

Authors:  J P Barnard; A M Friedlander
Journal:  Infect Immun       Date:  1999-02       Impact factor: 3.441

6.  Enzyme-linked immunosorbent assay using a recombinant baculovirus-expressed Bacillus anthracis protective antigen (PA): measurement of human anti-PA antibodies.

Authors:  L C Iacono-Connors; J Novak; C Rossi; J Mangiafico; T Ksiazek
Journal:  Clin Diagn Lab Immunol       Date:  1994-01

7.  Anthrax vaccine design: strategies to achieve comprehensive protection against spore, bacillus, and toxin.

Authors:  Julia Y Wang; Michael H Roehrl
Journal:  Med Immunol       Date:  2005-03-24
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.